An experimental drug could prolong this Parkville girl's life, but it costs $20,000 per month
In January, the Anstaett family learned their eight-year-old daughter had Batten disease, a rare condition with a difficult — and eventually terminal — prognosis. The drug showing promise in slowing the disease isn't covered by their insurance because it's still in clinical trials.
Source: kcur.org
/cloudfront-us-east-1.images.arcpublishing.com/gray/2QDU75E3WVCLDPQFSPQN6GLANQ.jpg)